Bräunlich S, Scheinert S, Schmidt A, Biamino G, Storck M, Scheinert D
Abteilung für Klinische und Interventionelle Angiologie, Universität Leipzig-Herzzentrum, Leipzig.
Chirurg. 2003 Dec;74(12):1103-9. doi: 10.1007/s00104-003-0772-x.
Acute limb ischemia is associated with a high risk of death and loss of the extremity. To restore the blood flow, several percutaneous thrombolytic techniques were developed. To achieve a targeted thrombus infiltration, the continuous application of low-dose urokinase or recombinant tissue plasminogen activator using a specific lysis catheter with sideholes is preferable. Concerning the amputation-free survival, thrombolysis is superior to surgery for occlusions of native vessels or bypass grafts that are not older than 2 weeks. Furthermore, the percutaneous approach permits the simultaneous treatment of the underlying lesion by angioplasty or stent implantation after dissolution of the occluding thrombus. The higher risk of complications must be balanced against risks of surgery in each patient.
急性肢体缺血与高死亡风险和肢体丧失相关。为恢复血流,已开发出多种经皮溶栓技术。为实现靶向血栓浸润,使用带有侧孔的特定溶栓导管持续应用低剂量尿激酶或重组组织型纤溶酶原激活剂更为可取。关于无截肢生存率,对于不超过2周的天然血管或旁路移植血管闭塞,溶栓优于手术。此外,经皮途径允许在闭塞血栓溶解后通过血管成形术或支架植入同时治疗潜在病变。必须针对每位患者权衡较高的并发症风险与手术风险。